FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1172394004: Itolizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4624097016 Itolizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4624098014 Itolizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4624097016 Itolizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4624098014 Itolizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Itolizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely itolizumab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Itolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely itolizumab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Itolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only itolizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Itolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing itolizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Itolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Itolizumab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Itolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only itolizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Itolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely itolizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Itolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely itolizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Itolizumab Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start